SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is seeing intense community debate as the stock undergoes a sharp pullback, with bulls treating the dip as a strategic buying opportunity driven by sustained AI memory demand, while bears argue the recent parabolic run-up is unsustainable and vulnerable to broader market corrections. Conversations are heavily focused on navigating the volatility, evaluating the long-term AI-driven supercycle, and analyzing the potential impact of labor tensions at key memory competitors.

Digi Power X, Inc. is a block chain technology company, which engages in crypto currency mining. It focuses on validation through mining, hosting solutions, and blockchain software solutions. It operates through the following segments: Cryptocurrency Mining, Sales of Energy and Electricity, and Colocation Services. The company was founded on February 18, 2017, and is headquartered in Miami, FL.

Digi Power X Inc. - Ordinary Shares (Sub voting)

Digi Power X is trending as investors react to a significant multi-billion dollar AI data center contract with Cerebras, positioning the stock as a key infrastructure proxy ahead of the high-profile Cerebras IPO. The community remains focused on the company's aggressive capacity expansion and potential for valuation rerating, while actively debating the impact of recent ATM share offerings on near-term price momentum.

The Wendy’s Co. engages in operating, developing, and franchising a system of quick-service restaurants. It operates through the following segments: Wendy’s U.S., Wendy’s International, and Global Real Estate and Development. The Wendy’s U.S. segment includes the operation and franchising of Wendy’s restaurants in the U.S. The Wendy’s International segment is involved in the operation and franchising of Wendy’s restaurants in countries and territories other than the U.S. The Global Real Estate and Development segment focuses on real estate activity for owned sites and sites leased from third parties. The company was founded by R. David Thomas on November 15, 1969 and is headquartered in Dublin, OH.

Wendy`s Co - Ordinary Shares - Class A

Wendy's Co

Wendy's is attracting significant attention as community members discuss a potential take-private bid by Trian Fund Management, which has fueled intense speculation regarding a major short squeeze given the stock's high short interest. Investors are actively debating the viability of this buyout and weighing it against international expansion efforts and recent earnings performance.

WORK Medical Technology Group Ltd. engages in the development of health instruments. It manufactures and sells medical devices, including endotracheal tubes, laryngeal mask airways, heat and moisture exchanging filters, disposable breathing circuits, nebulizer kits, and yankauer suction sets. The company was founded on March 1, 2022 and is headquartered in Hangzhou, China.

Work Medical Technology Group Ltd - Ordinary Shares - Class A

Work Medical Technology Group Ltd

Work Medical Technology Group is seeing intense volatility and significant volume, driven by community enthusiasm surrounding potential AI-healthcare expansion and recent speculative trading patterns. While some investors are chasing the stock's rapid intraday swings and parabolic move, others are expressing caution and debating its long-term viability as a small-cap China-based play.

Quantum Computing, Inc. engages in developing novel algorithms and solutions utilizing quantum and quantum-inspired computing to solve difficult problems in various industries. It leverages its expertise in finance, computing, security, mathematics, and physics to develop commercial applications for the financial, security, and government sectors. The company was founded on July 25, 2001 and is headquartered in Hoboken, NJ.

Quantum Computing Inc

Quantum Computing Inc. is experiencing significant market interest driven by an upcoming earnings report, with the community closely tracking its transition from research to commercial hardware and photonic technology. Investors are actively discussing the stock's potential for a short squeeze, fueled by high short interest and institutional accumulation, while monitoring technical levels as it faces critical resistance following a period of high volume.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group is seeing significant upward momentum as investors rotate capital out of tech and into defensive healthcare stocks, with the community actively tracking institutional accumulation and a potential move toward higher price levels. Sentiment is buoyed by corporate buyback programs, improved medical loss ratios, and ongoing discussions about the company's long-term resilience as a vertically integrated industry leader.

Roundhill ETF Trust - Roundhill Memory ETF

Investors are aggressively buying dips in the Roundhill Memory ETF as structural demand for AI-driven memory chips, particularly High Bandwidth Memory, keeps supply tight. The community remains overwhelmingly bullish on the sector's long-term supercycle, viewing current volatility as noise while anticipating further price appreciation driven by data center infrastructure needs.

Venture Global, Inc. engages in the provision of United States liquefied natural gas sourced from resource rich North American natural gas basins. It operates through the following segments: Calcasieu Project, Plaquemines Project, CP2 Project, and Sales and shipping. The company was founded by Michael Sabel and Robert Pender in 2023 and is headquartered in Arlington, VA.

Venture Global Inc. - Ordinary Shares - Class A

Venture Global Inc

Venture Global is trending as investors digest a major upward revision to the company's EBITDA guidance, driven by significant production growth and highly lucrative spot market sales. Community discussion is heavily focused on the stock's massive upside potential and its critical role in the global energy supply chain, with many longs actively calling for a squeeze against short sellers amid persistent geopolitical tensions.

Kopin Corp. engages in the development, manufacture and sale of wearable technologies which include components and systems. Its portfolio includes AMLCD, LCOS displays, OLED displays, ASIC, backlights, and optical lenses. The firm uses semiconductor material technology to design, manufacture and market its component products for use in military, enterprise and consumer electronic applications, training and simulation equipment and 3D metrology equipment. The company was founded by John C.C. Fan on April 23, 1984 and is headquartered in Westborough, MA.

Kopin Corp.

Kopin Corp

Kopin Corp is trending as investors bet on the company's emerging pivot from a defense supplier to an AI infrastructure player, fueled by a strategic partnership involving proprietary MicroLED optical interconnect technology. The community is actively discussing its potential to address industry bottlenecks alongside speculation surrounding recent non-disclosure agreements with major semiconductor firms.

Fundrise Innovation Fund LLC operates as a non-diversified, closed-end management investment company. It invests in growing tech companies to help them expand and generate profits. The company was founded on June 7, 2021 and is headquartered in Washington, DC.

Fundrise Innovation Fund LLC. - Common Shares of Limited Liability Company Interests

Fundrise Innovation Fund 

VCX is experiencing significant volatility and aggressive volume as retail traders debate its valuation relative to its underlying private AI and tech assets. Community sentiment is deeply polarized, with bulls pointing to the fund's indirect exposure to high-profile unicorns while bears focus on the massive premium over Net Asset Value and concerns regarding institutional selling.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Alkermes Gains Momentum After Sleep Disorder Trial Clears Key Hurdles

Alkermes shares climbed after phase 3 LUMRYZ data met key endpoints in idiopathic hypersomnia as analysts raised price targets.read more...

Alkermes Announces Positive Topline Results From REVITALYZ Phase 3 Study Evaluating LUMRYZ (sodium oxybate) Extended-Release in Adults With Idiopathic Hypersomnia

Alkermes plc (Nasdaq: ALKS) today announced positive topline results from the REVITALYZ double-blind, placebo-controlled, randomized withdrawal, multicenter phase 3 study evaluating the investigational use of LUMRYZ (sodium oxybate) extended-release oral suspension in adults with idiopathic...

Alkermes Analysts Increase Their Forecasts Following Strong Q1 Results

Alkermes reports positive Q1 results, beating expectations. Raises EPS guidance and maintains sales guidance. Analysts raise price targets.read more...

Alkermes' Q1 Earnings & Revenues Beat Estimates, Stock Rises

ALKS beats Q1 estimates as strong proprietary drug sales lift revenues by 28%, sending shares higher, while Lumryz adds a fresh growth driver.

Alkermes (NASDAQ:ALKS) Price Target Raised to $44.00 at Wells Fargo & Company

Wells Fargo & Company boosted their price target on shares of Alkermes from $43.00 to $44.00 and gave the company an "overweight" rating in a report on Wednesday...

Alkermes (NASDAQ:ALKS) Price Target Raised to $50.00 at Needham & Company LLC

Needham & Company LLC increased their target price on Alkermes from $45.00 to $50.00 and gave the company a 'buy' rating in a research note on Wednesday...

Alkermes (NASDAQ:ALKS) Reaches New 12-Month High  - Time to Buy?

Alkermes (NASDAQ:ALKS) Reaches New 52-Week High - Time to Buy...

Alkermes (ALKS) Q1 2026 Earnings Transcript

@media (max-width: 768px) {
 .image-container {
 width: 100% !important;
 float: none !important;
 margin: 0 0 1rem 0 !important;
 }
 }

Image source: The Mo...

Alkermes Q1 Earnings Call Highlights

Alkermes (NASDAQ:ALKS) executives highlighted a strong start to 2026 and the completion of the Avadel Pharmaceuticals acquisition during the company's first-quarter earnings call, pointing to...

Alkermes (ALKS) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

While the top- and bottom-line numbers for Alkermes (ALKS) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Alkermes Plc is a global biopharmaceutical company, which engages in the business of developing, manufacturing, and commercializing medicines designed to address unmet medical needs of patients in major therapeutic areas such as alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder, and a pipeline of product candidates in development for neurological disorders and cancer. Its proprietary products include ARISTADA, ARISTADA INITIO, LYBALVI, and VIVITROL. The company was founded in 1987 and is headquartered in Dublin, Ireland.

ALKS
Alkermes plc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Compact View

Poll

Latest ALKS News

ALKSAlkermes plc